https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
eness modeling, further study of the natural progression and treatment of ALVD and external validation of AI-ECG should be undertaken. Traditionally, peritoneal surface malignancies (PSM) were considered terminal diseases because of their advanced nature, therefore, systemic chemotherapy was given with palliative intent only. As a result, very poor survival outcomes were observed. But with the introduction of complete Cytoreductive surgery (CRS) and Hyperthermic intraperitoneal chemotherapy (HIPEC), the scenario has changed
Like
Comment
Share
